Comparatively, patients with AD, ALS, FTD, LBD, and PSP have been shown to have CSF NfL levels approximately 2.3-fold, 7.2-fold, 3-fold, 2.8-fold, and 3.5-fold higher than healthy controls, respectively (82). The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.